Back to top

Top Ranked Value Stocks to Buy for February 26th

Read MoreHide Full Article

Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 26th:

Ternium S.A. (TX - Free Report) : This steel products manufacturer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 2.1% over the last 60 days.

Ternium S.A. Price and Consensus

Ternium has a price-to-earnings ratio (P/E) of 6.18 compared with 11.30 for the industry. The company possesses a Value Score of A.

Ternium S.A. PE Ratio (TTM)

Lannett Company, Inc. (LCI - Free Report) : This manufacturer of generic versions of brand pharmaceutical products has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.9% over the last 60 days.

Lannett Co Inc Price and Consensus

Lannett has a price-to-earnings ratio (P/E) of 4.43 compared with 11.30 for the industry. The company possesses a Value Scoreof A.

Lannett Co Inc PE Ratio (TTM)

DXC Technology Company (DXC - Free Report) : This information technology services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.

DXC Technology Company. Price and Consensus

DXC Technology has a price-to-earnings ratio (P/E) of 8.09 compared with 13.40 for the industry. The company possesses a Value Score of A.

DXC Technology Company. PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Ternium S.A. (TX) - free report >>

Lannett Co Inc (LCI) - free report >>

DXC Technology Company. (DXC) - free report >>